Visium Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Visium Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-152,100	Closed	-$3.77M	–	545
2016 Q1	$3.77M	Buy	152,100 +50,000	+49%	+$1.37M	0.06%	313
2015 Q4	$3.59M	Buy	102,100 +77,100	+308%	+$2.07M	0.05%	332
2015 Q3	$529K	Buy	+25,000	New	+$644K	0.01%	570
2014 Q3	–	Sell	-319,199	Closed	-$8.75M	–	1299
2014 Q2	$8.75M	Buy	319,199 +12,241	+4%	+$326K	0.14%	149
2014 Q1	$8.09M	Buy	+306,958	New	+$8.81M	0.13%	151

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Visium Asset Management's GHDX Position: Q2 2016 in Review

Visium Asset Management sold out of Genomic Health, Inc. (GHDX) in Q2 2016, closing a stake of 152,100 shares — an estimated $3.77M sold.

Visium Asset Management first reported a position in GHDX in Q1 2014 and held it in 5 quarters. The position peaked at $8.75M in Q2 2014. 130 funds tracked by Wall St. Rank hold GHDX as of Q2 2016.

Visium Asset Management reported no remaining Genomic Health, Inc. position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 152,100 Genomic Health, Inc. shares in Q2 2016, an estimated $3.77M.
Visium Asset Management first reported a position in Genomic Health, Inc. in Q1 2014 and held it in 5 quarters.
Visium Asset Management's Genomic Health, Inc. position peaked at $8.75M in Q2 2014.
130 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.